A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61P 3/00 (2006.01) A61P 3/10 (2006.01) A61P 9/10 (2006.01) A61P 19/08 (2006.01)
Patent
CA 2663069
The present invention relates to methods and compositions for treating and diagnosing disorders related to energy metabolism and the OST-PTP signaling pathway involving gamma-carboxylase, osteocalcin and adiponectin. Such disorders include, but are not limited to, metabolic syndrome, glucose intolerance, diabetes types 1 and 2, atherosclerosis and obesity.
La présente invention concerne des méthodes et des compositions de traitement et de diagnostic des troubles associés au métabolisme énergétique et à la voie de signalisation OST-PTP impliquant la gamma-carboxylase, l'ostéocalcine et l'adiponectine. Lesdits troubles comprennent, entre autres, le syndrome métabolique, l'intolérance au glucose, le diabète de type 1 et de type 2, l'athérosclérose et l'obésité.
Ducy Patricia F.
Karsenty Gerard
Ducy Patricia F.
Gowling Lafleur Henderson Llp
Karsenty Gerard
The Trustees Of Columbia University In The City Of New York
LandOfFree
Undercarboxylated/uncarboxylated osteocalcin increases... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Undercarboxylated/uncarboxylated osteocalcin increases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Undercarboxylated/uncarboxylated osteocalcin increases... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1490200